![PDF) Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling PDF) Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling](https://i1.rgstatic.net/publication/322571616_Efficacy_and_Safety_of_Cyclophosphamide_Treatment_in_Severe_Juvenile_Dermatomyositis_Shown_by_Marginal_Structural_Modeling/links/5ad8de0f458515c60f5a6166/largepreview.png)
PDF) Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling
![PDF) Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients PDF) Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients](https://i1.rgstatic.net/publication/340660031_Retrospective_analysis_of_infliximab_and_adalimumab_treatment_in_a_large_cohort_of_juvenile_dermatomyositis_patients/links/5fc360d792851c933f7242c9/largepreview.png)
PDF) Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients
Muscle biopsy in combination with myositis‐specific autoantibodies aids prediction of outcomes in juvenile dermatomyositis
![Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis - Deakin - 2016 - Arthritis & Rheumatology - Wiley Online Library Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis - Deakin - 2016 - Arthritis & Rheumatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6d3f64da-56d1-42c3-9f51-8e9ac4390d7e/art39753-fig-0001-m.jpg)
Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis - Deakin - 2016 - Arthritis & Rheumatology - Wiley Online Library
![Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients | Arthritis Research & Therapy | Full Text Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-020-02164-5/MediaObjects/13075_2020_2164_Fig2_HTML.png)
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients | Arthritis Research & Therapy | Full Text
![Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients | Arthritis Research & Therapy | Full Text Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-020-02164-5/MediaObjects/13075_2020_2164_Fig1_HTML.png)